About 1,578,622 results (2,730 milliseconds)

Ten Common Mistakes in the Management of Lupus Nephritis

https://groups.google.com/group/fhcgvnefro/attach/bfcc5fd085a1c5de/erros%20comuns%20no%20manuseio%20da%20nefrite%20lupica%202014.pdf?part=0.1
Dec 13, 2013 ... This is due to concerns related to the multiple side effects of prednisone ... A controlled study of short-term pred- · nisone treatment in adults ...

WO2010099587A1 - Medicinal cosmetic lipoatrophy - Google Patents

https://patents.google.com/patent/WO2010099587A1/en
... Prednisone, Prednisolone tebutate, Triamcinolone and ... Recently, a review show that the side effects of short-term oral corticosteroids ...

JP2012519189A - Medical beauty fat atrophy method - Google Patents

https://patents.google.com/patent/JP2012519189A/en
... prednisone, prednisolone tebutate, triamcinolone and ... These events are rare and most treatments with short-term corticosteroids do not cause problems.

US20040261631A1 - Anaerobic tea steeper and method of use ...

https://patents.google.com/patent/US20040261631A1/en
... harmful effects of free radicals. For example, the flavonoids can ... Prednisone, Cyclophosphomide and Doxorubicin), administered over a nine week period.

RU2530629C2 - Drug-induced lipoatrophy for cosmetic purposes ...

https://patents.google.com/patent/RU2530629C2/en
Injectable corticosteroids currently used in medicine include short-acting injectable corticosteroids such as cortisone and hydrocortisone; medium-term ...

US20160067317A1 - Methods of treating pulmonary sarcoidosis ...

https://patents.google.com/patent/US20160067317A1/en
and are not usable for chronic or long term therapy because of these adverse drug responses. In some patients, corticosteroids slow or reverse the course of ...

US20130287774A1 - Prevention of Adverse Effects Caused by CD3 ...

https://patents.google.com/patent/US20130287774A1/en21
adverse effects can be classified in 5 grades in accordance with the Common Terminology Criteria for Adverse Events (CTCAE). ... prednisone, prednisolone ...

WO2017075150A1 - Method of treatment for third spacing - Google ...

https://patents.google.com/patent/WO2017075150A1/en
May 4, 2017 ... ... harmful to the overall wellbeing of the patient. As such ... risks associated with them with short and long term use, especially steroids.

EP1679962A1 - Zeolite molecular sieves for the removal of toxins ...

https://patents.google.com/patent/EP1679962A1/en
Effective therapy exists for lowering blood lead levels, however the long- term adverse ... Readministration with prednisone can be successful. Lifelong ...

US20050234024A1 - Materials and methods for the treatment of ...

https://patents.google.com/patent/US20050234024A1/en
These drugs affect the body's ability to create and maintain inflammation. Although steroids can be quite effective for short-term control of acute episodes of ...

US20090136445A1 - Sustained release eye drop formulations ...

https://patents.google.com/patent/US20090136445A1/en
Current topical eye drop formulations, in addition to often eliciting some degree of transient irritation, provide only short term exposure of beneficial agents ...

US6497890B2 - Anti-wrinkle preparation and method of reducing ...

https://patents.google.com/patent/US6497890B2/en
In the short run, low dose corticosteroids ... However, prolonged administration should be avoided because of long term adverse effects, even with low dosage ...

EP3191090A2 - Mucolytic agents for use in tretaing pulmonary ...

https://patents.google.com/patent/EP3191090A2/en
) and are not usable for chronic or long term therapy because of these adverse drug responses. In some patients, corticosteroids slow or reverse the course ...

US11986469B2 - Methods of treating prostate cancer - Google Patents

https://patents.google.com/patent/US11986469B2/en
Fizazi et al.., "Low Incidence of Corticosteroid-associated Adverse Events on long-term Exposure to Low-dose Prednisone Given wilh Abiralerone Acetate to ...

US10130638B2 - Prevention of adverse effects caused by CD3 ...

https://patents.google.com/patent/US10130638B2/en21
adverse effects can be classified in 5 grades in accordance with the Common Terminology Criteria for Adverse Events (CTCAE). ... prednisone, prednisolone ...

WO2020011938A1 - Glucocorticoids for the topical treatment of ...

https://patents.google.com/patent/WO2020011938A1/en
Jan 16, 2020 ... ... steroid- associated systemic side effects, in particular by long-term administration of systemically effective steroids. Therefore, systemic ...

US11084876B2 - Anti-leukocyte adhesion for the mitigation of ...

https://patents.google.com/patent/US11084876B2/en
Influence of Blinatumomab (AMG 103) on T cell-rolling on recombinant human adhesion molecules under semi short-term conditions. ... The term “clinical adverse ...

WO2013083809A1 - Prevention of adverse effects caused by ...

https://patents.google.com/patent/WO2013083809A1/en
In order to evaluate safety and tolerability of the anti-EpCAM x anti-CD3 bispecific single chain antibody, the compound has been administered by long-term ...

US5304574A - Methods of treatment of clinical conditions using ...

https://patents.google.com/patent/US5304574A/en
... risks involved, especially when these drugs are administered on a long term basis. Briefly, suspected side effects of the androgenic-anabolic steroids ...

ES2642312T3 - Corticosteroids for the treatment of joint pain ...

https://patents.google.com/patent/ES2642312T3/en
In some embodiments, the corticosteroid released by the microparticle formulation retains efficacy for a period of time that is at least twice as long, at least ...